Martingale Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-3,801
| Closed | -$649K | – | 909 |
|
2020
Q4 | $649K | Sell |
3,801
-1,302
| -26% | -$222K | 0.01% | 557 |
|
2020
Q3 | $717K | Buy |
5,103
+1,099
| +27% | +$154K | 0.01% | 718 |
|
2020
Q2 | $643K | Buy |
+4,004
| New | +$643K | 0.01% | 831 |
|
2019
Q2 | – | Sell |
-3,703
| Closed | -$442K | – | 1062 |
|
2019
Q1 | $442K | Buy |
+3,703
| New | +$442K | ﹤0.01% | 900 |
|
2018
Q2 | – | Sell |
-10,607
| Closed | -$786K | – | 1013 |
|
2018
Q1 | $786K | Buy |
+10,607
| New | +$786K | 0.01% | 762 |
|